Ipo Coimbra

Coimbra 3000-075

0 studies enrolling now · 3 studies all time

What they study most

Bladder Cancer, Carcinoma, Transitional Cell, Head and Neck Cancer, Squamous Cell Cancer

Studies at this site

• A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) — Running, not enrolling
• Zalutumumab in Non-curable Patients With SCCHN — Completed
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed